Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer

Background The role of adjuvant chemotherapy in patients with stage II colon cancer is unclear. Current guidelines recommend adjuvant chemotherapy for high‐risk patients, although the benefit demonstrated to date is small. Our study examined if adjuvant chemotherapy is associated with improved cancer‐specific survival in high‐risk patients with stage II colon cancer. Methods A retrospective review was performed on patients with stage II ( T 3‐4...